To better understand the molecular changes underlying CD133+ liver CSC-driven HCC tumor progression, we further performed gene expression profiling by comparing the transcriptome profiles between the CD133+ liver CSC group and CD133- counterpart. This evidence concerns the gene PROM1 and hepatocellular carcinoma.